Pancreatic cancer (PC) is anticipated to be second only to lung cancer as the leading cause
of cancer-related deaths in the United States by 2030. Surgery remains the only potentially …

The tumour microenvironment is of critical importance in cancer development and
progression and includes the surrounding stromal and immune cells, extracellular matrix …

Simple Summary Magnetic resonance imaging (MRI) has several advantages over
computerized tomography (CT) in the treatment planning of central nervous system (CNS) …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases with a
poor 5-year survival rate. PDAC cells rely on various metabolic pathways to fuel their …

Simple Summary Stereotactic body radiotherapy (SBRT) is an effective radiation therapy
technique that heavily relies upon daily image guidance to achieve the necessary precision …

Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive pancreatic cancer
with poor survival rate. Circular RNAs (circRNAs) signatures have been identified in some …

Detecting and mapping metabolism in tissues represents a major step in detecting,
characterizing, treating and understanding cancers. Recently introduced deuterium …

Alpha-ketoglutarate (α-KG) is a key metabolite and signaling molecule in cancer cells, but
the low permeability of α-KG limits the study of α-KG mediated effects in vivo. Recently, cell …

Background: There is an unmet need for noninvasive imaging markers that can help identify
the aggressive subtype (s) of pancreatic ductal adenocarcinoma (PDAC) at diagnosis and at …

Background Pancreatic ductal adenocarcinoma (PDA) is the third leading cause of cancer‐
related death in the United States. However, early response assessment using the current …